BiotechTube
Home/DermBiont/Nichola (Nick) Eliovits
N(

Nichola (Nick) Eliovits

Chief Financial Officer, Co-founder

DermBiont

Therapeutic Areas

DermatologyHyperpigmentation Disorders

DermBiont Pipeline

DrugIndicationPhase
SM-030Melasma and other hyperpigmentation disorders of the skinUnknown

Leadership Team at DermBiont

KB
Karl Beutner, MD, PhD
Chief Executive Officer, Co-founder
MN
Max N. Dawson
Chief Operating Officer
ET
Emma Taylor, MD
Advisor, Dermatology
View full DermBiont profile